Source author record

Hrithwik Shalu

Hrithwik Shalu appears in the imported research catalog. Authorship, coauthor and topic links are available while profile ownership is still unclaimed.

ResearcherUnclaimed source record

Catalog footprint

What is connected

5works
7topics
4close collaborators

Actions

Connect this record

Log in to claim

Research graph

See the researcher in context

Open full explorer

Inspect adjacent papers, topics, institutions and collaborators without losing the researcher page.

Building this map preview

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

5 published item(s)

preprint2022arXiv

Deep reinforcement learning for fMRI prediction of Autism Spectrum Disorder

Purpose : Because functional MRI (fMRI) data sets are in general small, we sought a data efficient approach to resting state fMRI classification of autism spectrum disorder (ASD) versus neurotypical (NT) controls. We hypothesized that a Deep Reinforcement Learning (DRL) classifier could learn effectively on a small fMRI training set. Methods : We trained a Deep Reinforcement Learning (DRL) classifier on 100 graph-label pairs from the Autism Brain Imaging Data Exchange (ABIDE) database. For comparison, we trained a Supervised Deep Learning (SDL) classifier on the same training set. Results : DRL significantly outperformed SDL, with a p-value of 2.4 x 10^(-7). DRL achieved superior results for a variety of classifier performance metrics, including an F1 score of 76, versus 67 for SDL. Whereas SDL quickly overfit the training data, DRL learned in a progressive manner that generalised to the separate testing set. Conclusion : DRL can learn to classify ASD versus NT in a data efficient manner, doing so for a small training set. Future work will involve optimizing the neural network for data efficiency and applying the approach to other fMRI data sets, namely for brain cancer patients.

preprint2022arXiv

Direct evaluation of progression or regression of disease burden in brain metastatic disease with Deep Neuroevolution

Purpose: A core component of advancing cancer treatment research is assessing response to therapy. Doing so by hand, for example as per RECIST or RANO criteria, is tedious, time-consuming, and can miss important tumor response information; most notably, they exclude non-target lesions. We wish to assess change in a holistic fashion that includes all lesions, obtaining simple, informative, and automated assessments of tumor progression or regression. Due to often low patient enrolments in clinical trials, we wish to make response assessments with small training sets. Deep neuroevolution (DNE) can produce radiology artificial intelligence (AI) that performs well on small training sets. Here we use DNE for function approximation that predicts progression versus regression of metastatic brain disease. Methods: We analyzed 50 pairs of MRI contrast-enhanced images as our training set. Half of these pairs, separated in time, qualified as disease progression, while the other 25 images constituted regression. We trained the parameters of a relatively small CNN via mutations that consisted of random CNN weight adjustments and mutation fitness. We then incorporated the best mutations into the next generations CNN, repeating this process for approximately 50,000 generations. We applied the CNNs to our training set, as well as a separate testing set with the same class balance of 25 progression and 25 regression images. Results: DNE achieved monotonic convergence to 100% training set accuracy. DNE also converged monotonically to 100% testing set accuracy. Conclusion: DNE can accurately classify brain-metastatic disease progression versus regression. Future work will extend the input from 2D image slices to full 3D volumes, and include the category of no change. We believe that an approach such as our could ultimately provide a useful adjunct to RANO/RECIST assessment.

preprint2021arXiv

Deep Neural Network Based Differential Equation Solver for HIV Enzyme Kinetics

Purpose: We seek to use neural networks (NNs) to solve a well-known system of differential equations describing the balance between T cells and HIV viral burden. Materials and Methods: In this paper, we employ a 3-input parallel NN to approximate solutions for the system of first-order ordinary differential equations describing the above biochemical relationship. Results: The numerical results obtained by the NN are very similar to a host of numerical approximations from the literature. Conclusion: We have demonstrated use of NN integration of a well-known and medically important system of first order coupled ordinary differential equations. Our trial-and-error approach counteracts the system's inherent scale imbalance. However, it highlights the need to address scale imbalance more substantively in future work. Doing so will allow more automated solutions to larger systems of equations, which could describe increasingly complex and biologically interesting systems.

preprint2020arXiv

A Data-Efficient Deep Learning Based Smartphone Application For Detection Of Pulmonary Diseases Using Chest X-rays

This paper introduces a paradigm of smartphone application based disease diagnostics that may completely revolutionise the way healthcare services are being provided. Although primarily aimed to assist the problems in rendering the healthcare services during the coronavirus pandemic, the model can also be extended to identify the exact disease that the patient is caught with from a broad spectrum of pulmonary diseases. The app inputs Chest X-Ray images captured from the mobile camera which is then relayed to the AI architecture in a cloud platform, and diagnoses the disease with state of the art accuracy. Doctors with a smartphone can leverage the application to save the considerable time that standard COVID-19 tests take for preliminary diagnosis. The scarcity of training data and class imbalance issues were effectively tackled in our approach by the use of Data Augmentation Generative Adversarial Network (DAGAN) and model architecture based as a Convolutional Siamese Network with attention mechanism. The backend model was tested for robustness us-ing publicly available datasets under two different classification scenarios(Binary/Multiclass) with minimal and noisy data. The model achieved pinnacle testing accuracy of 99.30% and 98.40% on the two respective scenarios, making it completely reliable for its users. On top of that a semi-live training scenario was introduced, which helps improve the app performance over time as data accumulates. Overall, the problems of generalisability of complex models and data inefficiency is tackled through the model architecture. The app based setting with semi live training helps in ease of access to reliable healthcare in the society, as well as help ineffective research of rare diseases in a minimal data setting.

preprint2020arXiv

Deep reinforcement learning to detect brain lesions on MRI: a proof-of-concept application of reinforcement learning to medical images

Purpose: AI in radiology is hindered chiefly by: 1) Requiring large annotated data sets. 2) Non-generalizability that limits deployment to new scanners / institutions. And 3) Inadequate explainability and interpretability. We believe that reinforcement learning can address all three shortcomings, with robust and intuitive algorithms trainable on small datasets. To the best of our knowledge, reinforcement learning has not been directly applied to computer vision tasks for radiological images. In this proof-of-principle work, we train a deep reinforcement learning network to predict brain tumor location. Materials and Methods: Using the BraTS brain tumor imaging database, we trained a deep Q network on 70 post-contrast T1-weighted 2D image slices. We did so in concert with image exploration, with rewards and punishments designed to localize lesions. To compare with supervised deep learning, we trained a keypoint detection convolutional neural network on the same 70 images. We applied both approaches to a separate 30 image testing set. Results: Reinforcement learning predictions consistently improved during training, whereas those of supervised deep learning quickly diverged. Reinforcement learning predicted testing set lesion locations with 85% accuracy, compared to roughly 7% accuracy for the supervised deep network. Conclusion: Reinforcement learning predicted lesions with high accuracy, which is unprecedented for such a small training set. We believe that reinforcement learning can propel radiology AI well past the inherent limitations of supervised deep learning, with more clinician-driven research and finally toward true clinical applicability.